Market closedNon-fractional
Alector/ALEC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Alector
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
Ticker
ALEC
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
South San Francisco, United States
Employees
244
Website
www.alector.com
Alector Metrics
BasicAdvanced
$425M
Market cap
-
P/E ratio
-$1.40
EPS
0.82
Beta
-
Dividend rate
Price and volume
Market cap
$425M
Beta
0.82
Financial strength
Current ratio
3.525
Quick ratio
3.408
Long term debt to equity
16.222
Total debt to equity
20.992
Management effectiveness
Return on assets (TTM)
-13.13%
Return on equity (TTM)
-66.65%
Valuation
Price to revenue (TTM)
3.953
Price to book
2.39
Price to tangible book (TTM)
2.39
Price to free cash flow (TTM)
-1.916
Growth
Revenue change (TTM)
-23.30%
Earnings per share change (TTM)
-14.37%
3-year revenue growth
74.84%
3-year earnings per share growth
-18.36%
What the Analysts think about Alector
Analyst Ratings
Majority rating from 11 analysts.
Alector Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$16M
4.64%
Net income
-$36M
-13.04%
Profit margin
-227.84%
-16.90%
Alector Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.02
-$0.53
-$0.49
-$0.38
-
Expected
-$0.82
-$0.66
-$0.77
-$0.51
-$0.50
Surprise
-102.44%
-19.36%
-36.44%
-25.16%
-
Alector News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Alector stock?
Alector (ALEC) has a market cap of $425M as of July 06, 2024.
What is the P/E ratio for Alector stock?
The price to earnings (P/E) ratio for Alector (ALEC) stock is 0 as of July 06, 2024.
Does Alector stock pay dividends?
No, Alector (ALEC) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Alector dividend payment date?
Alector (ALEC) stock does not pay dividends to its shareholders.
What is the beta indicator for Alector?
Alector (ALEC) has a beta rating of 0.82. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Alector stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.